Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Non-Small Cell Lunch Cancer × NVP-BKM120 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasm Metastasis 4 Prostatic Neoplasms 3 Breast Neoplasms 2 Brain Neoplasms 2 Skin Neoplasms 1 Non-Small Cell Lunch Cancer 1 Non Castrate Metastatic Prostate Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 Gliosarcoma 1 Glioblastoma 1 Esophageal Neoplasms 1 Carcinoma, Basal Cell 1 Basal Cell Nevus Syndrome 1

Interventions

Paclitaxel 1 NVP-BKM120 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01820325 2018-10-11

BASALT-2

Novartis

Phase 1 Terminated

Non-Small Cell Lunch Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡